Luoxin Pharmaceutical: Plans to acquire 19.05% stake in the holding subsidiary for 67.5605 million yuan.

On February 13, Luoxin Pharmaceutical announced that the company plans to acquire 19.0526% equity of Luoxin Health Technology Co., Ltd. held by Chengdu Deyi Xinhua Equity Investment Partnership Enterprise for 67,560,052 yuan. After the completion of the transaction, the company's stake in Beijing Health will increase from 80.9474% to 100%. Beijing Health was established in December 2020 and serves as the sales and promotion platform for the company's main products, focusing on the circulation of high-quality drugs in the digestive and antibacterial fields. After years of dedicated development, Beijing Health is currently profitable and its future profit-making ability and operational risks can be reliably estimated.